Blue Haven Rx review: price conflicts and the early renewal deadline

The homepage product cards advertise compounded semaglutide at $149 per month and tirzepatide at $179 per month. The opened pricing FAQ on that same page instead lists $179 for semaglutide and $259 for tirzepatide. Another homepage callout says $149 per month for three months. We confirmed the discrepancy in the rendered page, rather than assuming the lowest pair was a universal current rate.

The cards describe consultation, prescription if approved, four weeks of medication and free shipping, with the same price across doses. Those are attributed advertising claims. Ask for the exact selected plan, amount charged now, supplied quantity and recurring charge in writing. The headline monthly unit and a four-week supply do not, by themselves, establish a calendar-month renewal schedule.

The May 8 terms describe monthly, three-month, six-month and twelve-month subscriptions paid in full at the start of the selected term. They distinguish the amount paid from dispensing: the largest shipment is a twelve-week supply, with further shipments over a longer paid term. Paying for a year does not mean receiving a year of medication at once.

The terms describe preauthorization of the full plan amount, followed by capture if a provider approves a prescription and release if the provider declines. The opening membership paragraph instead says charging occurs when the intake is completed, while the homepage FAQ ties the charge to pharmacy submission after approval. Because those descriptions differ, confirm the actual capture event and retain the checkout terms. A temporary card hold can affect available funds even before settlement.

Once charged, the terms state that the programme fee is nonrefundable, except as required by applicable law. That wording covers the paid subscription term rather than just a vial already shipped. We did not test enforcement of the policy or determine an individual refund entitlement.

The terms allow a renewal charge up to ten days before the end of the current subscription term. They direct members to the Next payment field in the portal for the actual renewal date. To prevent that charge, cancellation must be submitted at least 48 hours before that date. Later requests stop subsequent renewals but do not prevent the impending charge under the stated policy.

This distinction matters for anyone looking at the medication supply calendar: the cancellation deadline can precede the last day of the current supply by considerably more than two days. Check the displayed payment date instead of calculating from an assumed monthly anniversary. The terms list portal cancellation, support@bluehavenrx.com and customer support by phone, and say portal cancellation takes effect on submission with email confirmation.

The terms say the earlier weight-loss guarantee ended April 13, 2026 for new members and members starting a subscription term after that date. They describe possible legacy eligibility under the terms of an original enrolment on or before that date. This is not a current general money-back promise for a person joining now.

The public terms also retain a drafting note calling for legal review and consistency checks before publication. That is a visible document-quality issue, not proof that a particular provision is enforceable or unenforceable. It strengthens the practical case for requesting the final agreement that applies to your own purchase.

The terms identify the operator as Eternum Health LLC, a New Jersey company doing business as Blue Haven Rx. They distinguish the platform from professional entities including Wasef Health practices and Beluga Health, P.A. The terms claim service availability in all 50 states and Washington, DC; we did not independently verify provider availability in each jurisdiction.

The homepage describes compounded products and uses the phrase “503A Outsourcing Facilities.” That wording needs clarification: FDA’s compounding Q&A distinguishes section 503A compounding from registered outsourcing facilities under section 503B. Neither category makes a compounded drug FDA-approved. Request the actual dispensing pharmacy, its address and the applicable regulatory category instead of treating that phrase as a verified credential.

Blue Haven advertises 24/7 portal messaging and a prescription within 12 hours. Its terms say published timelines for review, processing, shipment and delivery are estimates rather than guarantees. They describe expedited two-business-day shipping, where offered, as beginning after carrier pickup. None of those claims establishes an immediate medical reply or delivery two days after signup.

The homepage lists support@bluehavenrx.com and 310-744-1417, with weekday hours of 8 a.m.–8 p.m. Eastern and weekend hours of 8 a.m.–4 p.m. Eastern. These are company support hours, distinct from clinical coverage. The site also labels displayed GLP-1-user testimonials as paid; they are not independently established outcomes for Blue Haven’s own programme.

Get the final price, renewal date, full upfront commitment and nonrefund point together in one written explanation. Ask the clinician about the proposed product, follow-up and any testing needed; the homepage says blood work is not required but recommends it and accepts recent results. That statement should not replace an individual clinical assessment.

Our lab-testing questions guide separates a medical request from the laboratory’s bill. The Zealthy review compares another service whose bundle and general refund pages differ. Neither review assigns a clinical quality score or establishes that treatment is appropriate for a particular reader.